• 中国科技论文统计源期刊
  • 中国科技核心期刊
  • 中国高校优秀期刊
  • 安徽省优秀科技期刊
XU Huan-bai, SHI Jian-hua, ZHANG Xiao-mei, CHEN Feng-ling, YU Lei. Nateglinide in treatment of type 2 diabetes[J]. Journal of Bengbu Medical University, 2005, 30(3): 237-239.
Citation: XU Huan-bai, SHI Jian-hua, ZHANG Xiao-mei, CHEN Feng-ling, YU Lei. Nateglinide in treatment of type 2 diabetes[J]. Journal of Bengbu Medical University, 2005, 30(3): 237-239.

Nateglinide in treatment of type 2 diabetes

More Information
  • Received Date: September 08, 2004
  • Objective: To investigate the effect and safety of nateglinide in treatment of patients with type 2 diabetes mellitus.Methods: A randomized double blind control trial was followed up for twelve weeks.Forty-eight selected cases were randomly divided into two groups in the ratio of one to one:observation group (nateglinide) and control group (repaglinide).The 2 hours plasma glucose(2hPG) and HbAlc levels of the patients were observed.Results: 2hPG and HbAlc levels of the two groups decreased obviously after treatment(P<0.01).The decreasing levels of 2hPG and HbAlc of each group' had no obvious differences (P>0.05).Conclusions: Nateglinide is effective and safe for the treatment of type 2 diabetes mellitus with slight side effects.

Catalog

    Article views (2892) PDF downloads (15) Cited by()
    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return